FYI: posted in Reddit. Just someone’s thoughts on Adam.
“ I want to share something that’s been gnawing at me for a few months, and now, with recent events, the picture feels clearer.
Back in May 2025, I reached out to STAT News to pitch an opinion piece (not news reporting, just an opinion essay) about ImmunityBio. My idea was to highlight the patient stories, the scientific progress, and why I believe this company is positioned for a breakthrough moment in oncology.
I wasn’t asking to be a staff journalist, just to contribute an opinion piece. STAT regularly runs op-eds on a wide range of biotech topics. Yet my submission was flatly denied. The editor simply wrote back: “I’ll have to pass.” No explanation. No suggestion to resubmit. No feedback on why. Just a categorical “no.”
At the time, it felt odd. But I let it go.
Fast-forward to August 2025. Adam Feuerstein, STAT’s senior biotech writer, is on X posting very flippant, loaded commentary about ImmunityBio — framing questions around the data in a way that doesn’t invite balanced discussion, but instead feels dismissive, even discrediting. Criticism is fair, even necessary, but tone matters. And his tone wasn’t “inquiring journalist,” it was “here’s why this is junk.”
When I connect the dots (my own op-ed rejection with zero explanation, plus Feuerstein’s public posture in August) it leaves me questioning STAT’s stance on ImmunityBio. I’m not alleging a smoking gun. But to me, it signals a clear editorial bias.
And that’s troubling. Because ImmunityBio isn’t some penny-stock mirage — there are real patient stories, real survival signals, real regulatory designations, and real scientific credibility being built. To dismiss it out of hand, or block out independent voices trying to discuss it, feels like narrative management rather than journalism.
So I’m sharing this as context. Readers deserve to understand how stories are shaped, who sets the tone, and why certain companies are constantly framed through a skeptical (or hostile) lens while others get endless puff coverage.
As Dr. Soon-Shiong himself often says: “Connecting the Dots)
That’s the lens I’m applying here too.. Just a share” |
